These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12859618)

  • 61. Electron spin resonance studies of chloroquine-melanin complexes.
    Buszman E; Kopera M; Wilczok T
    Biochem Pharmacol; 1984 Jan; 33(1):7-11. PubMed ID: 6322795
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells.
    Capranico G; Soranzo C; Zunino F
    Cancer Res; 1986 Nov; 46(11):5499-503. PubMed ID: 3463414
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
    J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a promising new candidate for chemotherapeutic treatment of osteosarcoma patients.
    Pasello M; Hattinger CM; Stoico G; Manara MC; Benini S; Geroni C; Mercuri M; Scotlandi K; Picci P; Serra M
    Eur J Cancer; 2005 Sep; 41(14):2184-95. PubMed ID: 16140527
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Decreased resistance to N,N-dimethylated anthracyclines in multidrug-resistant Friend erythroleukemia cells.
    Schaefer A; Westendorf J; Lingelbach K; Schmidt CA; Mihalache DL; Reymann A; Marquardt H
    Cancer Chemother Pharmacol; 1993; 31(4):301-7. PubMed ID: 8422694
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cell surface-directed interaction of anthracyclines leads to cytotoxicity and nuclear factor kappaB activation but not apoptosis signaling.
    Maestre N; Tritton TR; Laurent G; Jaffrézou JP
    Cancer Res; 2001 Mar; 61(6):2558-61. PubMed ID: 11289131
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hematoporphyrin derivative and anthracyclines mutually inhibit cellular uptake and toxicity.
    Böhmer RM; Hoffmann K; Morstyn G
    Cancer Chemother Pharmacol; 1987; 20(1):16-20. PubMed ID: 3621448
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Increased toxicity of anthracycline antibiotics induced by calcium entry blockers in cultured cardiomyocytes.
    Santostasi G; Kutty RK; Krishna G
    Toxicol Appl Pharmacol; 1991 Mar; 108(1):140-9. PubMed ID: 2006501
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
    Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A
    Eur J Pharmacol; 2000 Mar; 391(3):207-16. PubMed ID: 10729360
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reversal of doxorubicin, etoposide, vinblastine, and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine.
    Gosland MP; Gillespie MN; Tsuboi CP; Tofiq S; Olson JW; Crooks PA; Aziz SM
    Cancer Chemother Pharmacol; 1996; 37(6):593-600. PubMed ID: 8612315
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potential.
    Della Torre P; Podestà A; Imondi AR; Moneta D; Sammartini U; Arrigoni C; Terron A; Brughera M
    Cancer Chemother Pharmacol; 2001 Apr; 47(4):355-60. PubMed ID: 11345653
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Metabolism of doxorubicin, daunorubicin and epirubicin in human and rat hepatoma cells.
    Le Bot MA; Glaise D; Kernaleguen D; Ratanasavanh D; Carlhant D; Riche C; Guillouzo A
    Pharmacol Res; 1991 Oct; 24(3):243-52. PubMed ID: 1659695
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nucleotide-induced conformational changes in the human multidrug resistance protein MRP1 are related to the capacity of chemotherapeutic drugs to accumulate or not in resistant cells.
    Manciu L; Chang X; Riordan JR; Buyse F; Ruysschaert JM
    FEBS Lett; 2001 Mar; 493(1):31-5. PubMed ID: 11278000
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nuclear targeting and nuclear retention of anthracycline-formaldehyde conjugates implicates DNA covalent bonding in the cytotoxic mechanism of anthracyclines.
    Taatjes DJ; Fenick DJ; Koch TH
    Chem Res Toxicol; 1999 Jul; 12(7):588-96. PubMed ID: 10409398
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Anthracycline resistance mediated by reductive metabolism in cancer cells: the role of aldo-keto reductase 1C3.
    Hofman J; Malcekova B; Skarka A; Novotna E; Wsol V
    Toxicol Appl Pharmacol; 2014 Aug; 278(3):238-48. PubMed ID: 24832494
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparative study of chronic toxic effects of daunorubicin and doxorubicin in rabbits.
    Klimtová I; Simůnek T; Mazurová Y; Hrdina R; Gersl V; Adamcová M
    Hum Exp Toxicol; 2002 Dec; 21(12):649-57. PubMed ID: 12540035
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Drug Distribution to Retinal Pigment Epithelium: Studies on Melanin Binding, Cellular Kinetics, and Single Photon Emission Computed Tomography/Computed Tomography Imaging.
    Rimpelä AK; Schmitt M; Latonen S; Hagström M; Antopolsky M; Manzanares JA; Kidron H; Urtti A
    Mol Pharm; 2016 Sep; 13(9):2977-86. PubMed ID: 26741026
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03.
    Escherich G; Zimmermann M; Janka-Schaub G;
    Pediatr Blood Cancer; 2013 Feb; 60(2):254-7. PubMed ID: 22948968
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Protection against daunorubicin cytotoxicity by expression of a cloned human carbonyl reductase cDNA in K562 leukemia cells.
    Gonzalez B; Akman S; Doroshow J; Rivera H; Kaplan WD; Forrest GL
    Cancer Res; 1995 Oct; 55(20):4646-50. PubMed ID: 7553643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.